OXAZAPHOSPHORINES AS BIOLOGICAL RESPONSE MODIFIERS - EXPERIMENTAL AND CLINICAL PERSPECTIVES

被引：39

作者：

HILGARD, P

POHL, J

STEKAR, J

VOEGELI, R

机构：

来源：

CANCER TREATMENT REVIEWS | 1985年 / 12卷 / 03期

关键词：

D O I：

10.1016/0305-7372(85)90036-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：155 / 162

页数：8

共 38 条

[1]

AKIYAMA J, 1977, CANCER RES, V37, P3042

[2] AUGMENTATION OF DELAYED-TYPE HYPERSENSITIVITY BY DOSES OF CYCLOPHOSPHAMIDE WHICH DO NOT AFFECT ANTIBODY-RESPONSES [J].

ASKENASE, PW ;

HAYDEN, BJ ;

GERSHON, RK .

JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 141 (03) :697-702

[3]

BALDWIN RW, 1983, CANCER CHEMOTHERAPY, P193

[4] CONTRASTING EFFECTS OF CYCLOPHOSPHAMIDE AND PREDNISOLONE ON THE PHENOTYPE OF HUMAN PERIPHERAL-BLOOD LEUKOCYTES [J].

BAST, RC ;

REINHERZ, EL ;

MAVER, C ;

LAVIN, P ;

SCHLOSSMAN, SF .

CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1983, 28 (01) :101-114

[5]

BERD D, 1982, CANCER RES, V42, P4862

[6]

BONAVIDA B, 1977, J IMMUNOL, V119, P1530

[7]

BROCK N, 1976, CHEMOTHERAPY, P19

[8] ANALYSIS OF SYNERGY BETWEEN CYCLOPHOSPHAMIDE THERAPY AND IMMUNITY AGAINST A MOUSE TUMOR [J].

CHASSOUX, DM ;

GOTCH, FM ;

MACLENNAN, ICM .

BRITISH JOURNAL OF CANCER, 1978, 38 (02) :211-218

[9]

CHIRIGOS MA, 1982, IMMUNOLOGICAL APPROA, P191

[10]

COWENS JW, 1981, FED PROC, V40, P1096

← 1 2 3 4 →